288 related articles for article (PubMed ID: 27558924)
1. A coding variant in
Kim HS; Cheon JH; Jung ES; Park J; Aum S; Park SJ; Eun S; Lee J; Rüther U; Yeo GSH; Ma M; Park KS; Naito T; Kakuta Y; Lee JH; Kim WH; Lee MG
Gut; 2017 Nov; 66(11):1926-1935. PubMed ID: 27558924
[TBL] [Abstract][Full Text] [Related]
2. An intronic FTO variant rs16952570 confers protection against thiopurine-induced myelotoxicities in multiethnic Asian IBD patients.
Chen S; Tan WZ; Sutiman N; Lim C; Lee SS; Leong WF; Tjai M; Wang C; Kong CSC; Chuah SW; Schwender BJ; Chan W; Shim HH; Lim WC; Khor CC; Ling KL; Chowbay B
Pharmacogenomics J; 2020 Jun; 20(3):505-515. PubMed ID: 31813937
[TBL] [Abstract][Full Text] [Related]
3. NUDT15 codon 139 is the best pharmacogenetic marker for predicting thiopurine-induced severe adverse events in Japanese patients with inflammatory bowel disease: a multicenter study.
Kakuta Y; Kawai Y; Okamoto D; Takagawa T; Ikeya K; Sakuraba H; Nishida A; Nakagawa S; Miura M; Toyonaga T; Onodera K; Shinozaki M; Ishiguro Y; Mizuno S; Takahara M; Yanai S; Hokari R; Nakagawa T; Araki H; Motoya S; Naito T; Moroi R; Shiga H; Endo K; Kobayashi T; Naganuma M; Hiraoka S; Matsumoto T; Nakamura S; Nakase H; Hisamatsu T; Sasaki M; Hanai H; Andoh A; Nagasaki M; Kinouchi Y; Shimosegawa T; Masamune A; Suzuki Y;
J Gastroenterol; 2018 Sep; 53(9):1065-1078. PubMed ID: 29923122
[TBL] [Abstract][Full Text] [Related]
4. Systematic review with meta-analysis: risk factors for thiopurine-induced leukopenia in IBD.
van Gennep S; Konté K; Meijer B; Heymans MW; D'Haens GR; Löwenberg M; de Boer NKH
Aliment Pharmacol Ther; 2019 Sep; 50(5):484-506. PubMed ID: 31342537
[TBL] [Abstract][Full Text] [Related]
5. Genotype-based Treatment With Thiopurine Reduces Incidence of Myelosuppression in Patients With Inflammatory Bowel Diseases.
Chang JY; Park SJ; Jung ES; Jung SA; Moon CM; Chun J; Park JJ; Kim ES; Park Y; Kim TI; Kim WH; Cheon JH
Clin Gastroenterol Hepatol; 2020 Aug; 18(9):2010-2018.e2. PubMed ID: 31446180
[TBL] [Abstract][Full Text] [Related]
6. Combined Detection of NUDT15 Variants Could Highly Predict Thiopurine-induced Leukopenia in Chinese Patients with Inflammatory Bowel Disease: A Multicenter Analysis.
Chao K; Wang X; Cao Q; Qian J; Wu K; Zhu X; Yang H; Liang J; Lin L; Huang Z; Zhang Y; Huang Y; Sun Y; Xue X; Huang M; Hu P; Lan P; Gao X
Inflamm Bowel Dis; 2017 Sep; 23(9):1592-1599. PubMed ID: 28570428
[TBL] [Abstract][Full Text] [Related]
7. Influences of XDH genotype by gene-gene interactions with SUCLA2 for thiopurine-induced leukopenia in Korean patients with Crohn's disease.
Park SK; Hong M; Ye BD; Kim KJ; Park SH; Yang DH; Hwang SW; Kwak MS; Lee HS; Song K; Yang SK
Scand J Gastroenterol; 2016; 51(6):684-91. PubMed ID: 26863601
[TBL] [Abstract][Full Text] [Related]
8. Inosine triphosphate pyrophosphatase and thiopurine s-methyltransferase genotypes relationship to azathioprine-induced myelosuppression.
Zelinkova Z; Derijks LJ; Stokkers PC; Vogels EW; van Kampen AH; Curvers WL; Cohn D; van Deventer SJ; Hommes DW
Clin Gastroenterol Hepatol; 2006 Jan; 4(1):44-9. PubMed ID: 16431304
[TBL] [Abstract][Full Text] [Related]
9. Should thiopurine methyltransferase genotypes and phenotypes be measured before thiopurine therapy in patients with inflammatory bowel disease?
Fangbin Z; Xiang G; Minhu C; Liang D; Feng X; Min H; Pinjin H
Ther Drug Monit; 2012 Dec; 34(6):695-701. PubMed ID: 23149442
[TBL] [Abstract][Full Text] [Related]
10. Xanthine oxidase activity in thiopurine curative Chinese inflammatory bowel disease patients.
Ding L; Zhang FB; Liu H; Gao X; Bi HC; Huang L; Wang XD; Chen BL; Zhang Y; Lv C; Hu PJ; Huang M
Pharmacol Res Perspect; 2021 May; 9(3):e00764. PubMed ID: 33929082
[TBL] [Abstract][Full Text] [Related]
11. NUDT15 R139C causes thiopurine-induced early severe hair loss and leukopenia in Japanese patients with IBD.
Kakuta Y; Naito T; Onodera M; Kuroha M; Kimura T; Shiga H; Endo K; Negoro K; Kinouchi Y; Shimosegawa T
Pharmacogenomics J; 2016 Jun; 16(3):280-5. PubMed ID: 26076924
[TBL] [Abstract][Full Text] [Related]
12. Early Assessment of Thiopurine Metabolites Identifies Patients at Risk of Thiopurine-induced Leukopenia in Inflammatory Bowel Disease.
Wong DR; Coenen MJ; Vermeulen SH; Derijks LJ; van Marrewijk CJ; Klungel OH; Scheffer H; Franke B; Guchelaar HJ; de Jong DJ; Engels LG; Verbeek AL; Hooymans PM;
J Crohns Colitis; 2017 Feb; 11(2):175-184. PubMed ID: 27402913
[TBL] [Abstract][Full Text] [Related]
13. Leukopenia predicts remission in patients with inflammatory bowel disease and Behcet's disease on thiopurine maintenance.
Park MS; Kim DH; Kim DH; Park SJ; Hong SP; Kim TI; Kim WH; Cheon JH
Dig Dis Sci; 2015 Jan; 60(1):195-204. PubMed ID: 25239495
[TBL] [Abstract][Full Text] [Related]
14. Influences of thiopurine methyltransferase genotype and activity on thiopurine-induced leukopenia in Korean patients with inflammatory bowel disease: a retrospective cohort study.
Kim JH; Cheon JH; Hong SS; Eun CS; Byeon JS; Hong SY; Kim BY; Kwon SH; Kim SW; Han DS; Yang SK; Kim WH
J Clin Gastroenterol; 2010; 44(10):e242-8. PubMed ID: 20308917
[TBL] [Abstract][Full Text] [Related]
15. Frequency of thiopurine methyltransferase mutation in patients of Mediterranean area with inflammatory bowel disease and autoimmune disorders.
Di Salvo A; Fabiano C; Mannara V; Dimarco M; Orlando A; Affronti M; Macaluso FS; Cottone M
Dig Liver Dis; 2016 Dec; 48(12):1506-1509. PubMed ID: 27665263
[TBL] [Abstract][Full Text] [Related]
16. More Dose-dependent Side Effects with Mercaptopurine over Azathioprine in IBD Treatment Due to Relatively Higher Dosing.
Broekman MMTJ; Coenen MJH; van Marrewijk CJ; Wanten GJA; Wong DR; Verbeek ALM; Klungel OH; Hooymans PM; Guchelaar HJ; Scheffer H; Derijks LJJ; de Jong DJ;
Inflamm Bowel Dis; 2017 Oct; 23(10):1873-1881. PubMed ID: 28644183
[TBL] [Abstract][Full Text] [Related]
17. Timing of myelosuppression during thiopurine therapy for inflammatory bowel disease: implications for monitoring recommendations.
Lewis JD; Abramson O; Pascua M; Liu L; Asakura LM; Velayos FS; Hutfless SM; Alison JE; Herrinton LJ
Clin Gastroenterol Hepatol; 2009 Nov; 7(11):1195-201; quiz 1141-2. PubMed ID: 19631285
[TBL] [Abstract][Full Text] [Related]
18. Nucleoside diphosphate-linked moiety X-type motif 15 C415T variant as a predictor for thiopurine-induced toxicity in Indian patients.
Shah SA; Paradkar M; Desai D; Ashavaid TF
J Gastroenterol Hepatol; 2017 Mar; 32(3):620-624. PubMed ID: 27416873
[TBL] [Abstract][Full Text] [Related]
19.
Sato T; Takagawa T; Kakuta Y; Nishio A; Kawai M; Kamikozuru K; Yokoyama Y; Kita Y; Miyazaki T; Iimuro M; Hida N; Hori K; Ikeuchi H; Nakamura S
Intest Res; 2017 Jul; 15(3):328-337. PubMed ID: 28670229
[TBL] [Abstract][Full Text] [Related]
20. Long-term effect of NUDT15 R139C on hematologic indices in inflammatory bowel disease patients treated with thiopurine.
Akiyama S; Matsuoka K; Fukuda K; Hamada S; Shimizu M; Nanki K; Mizuno S; Kiyohara H; Arai M; Sugimoto S; Iwao Y; Ogata H; Hisamatsu T; Naganuma M; Motobayashi M; Suzuki K; Takenaka K; Fujii T; Saito E; Nagahori M; Ohtsuka K; Mochizuki M; Watanabe M; Hashiguchi M; Kanai T
J Gastroenterol Hepatol; 2019 Oct; 34(10):1751-1757. PubMed ID: 31045285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
